Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Eleena Koep"'
Autor:
Ami R. Buikema, Lee Brekke, Amy Anderson, Eleena Koep, Damon Van Voorhis, Lucie Sharpsten, Beth Hahn, Riju Ray, Richard H. Stanford
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background Chronic obstructive pulmonary disease (COPD) is associated with high clinical and economic burden. Optimal pharmacological therapy for COPD aims to reduce symptoms and the frequency and severity of exacerbations. Umeclidinium/vila
Externí odkaz:
https://doaj.org/article/897236101786485a904ae61d6fa15229
Publikováno v:
Pulmonary Circulation, Vol 9 (2018)
Several new medications for pulmonary arterial hypertension (PAH) have recently been introduced; however, current real-world data regarding US patients with PAH are limited. We conducted a retrospective administrative claims study to examine PAH trea
Externí odkaz:
https://doaj.org/article/f55acd6d11874dc9ba9c3f921129fd57
Autor:
Cosmina Hogea, Ami R Buikema, Patricia Novy, Gary S. Marshall, Parinaz Ghaswalla, Lindsay G S Bengtson, Tim Bancroft, Eleena Koep
Publikováno v:
Clinical Infectious Diseases. 75:155-158
Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within
Publikováno v:
The American journal of managed care. 27(7)
OBJECTIVES To measure variation in spending and inpatient prices associated with the primary care physician (PCP) practice to which patients are attributed. STUDY DESIGN Cross-sectional analysis of claims data. METHODS We used random effect models to
Publikováno v:
Current medical research and opinion. 37(10)
Serious mental illnesses (SMIs), including schizophrenia, bipolar disorder, and major depressive disorder (MDD), are often treated with antipsychotic medications. Unfortunately, medication non-adherence is widespread and is associated with serious ad
Publikováno v:
Pragmatic and Observational Research
Carolyn Martin,1 Eleena Koep,1 John White,1 Angela Belland,1 Heidi Waters,2 Felicia Forma3 1Optum, Eden Prairie, MN, USA; 2Policy Research Health Outcomes, Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA; 3Otsuka Pharma
Autor:
Beth Hahn, Chad Moretz, Lucie Sharpsten, Junliang Tong, Richard H. Stanford, Riju Ray, Lindsay G S Bengtson, Lisa Le, Eleena Koep
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2047-2060
Background This was the first real-world head-to-head study comparing inhaled long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combination treatments as maintenance therapy. Methods Retrospective observational study including comm
Autor:
Parinaz K, Ghaswalla, Gary S, Marshall, Lindsay G S, Bengtson, Ami R, Buikema, Tim, Bancroft, Eleena, Koep, Patricia, Novy, Cosmina S, Hogea
Publikováno v:
JAMA Network Open. 5:e228573
In the United States, individuals with HIV infection have been recommended to receive a 2-dose series of the meningococcal A, C, W, Y (MenACWY) vaccine since 2016 owing to their increased risk of meningococcal disease.To examine uptake and time to re
Autor:
Gary S. Marshall, Lindsay G S Bengtson, Cosmina Hogea, Ami R Buikema, Patricia Novy, Tim Bancroft, Eleena Koep, Parinaz Ghaswalla, Krista M. Schladweiler
Publikováno v:
Vaccine. 39(2)
Background Patients with asplenia are recommended to receive meningococcal ACWY (MenACWY) and B (MenB) vaccines in the United States (US). Objectives To examine uptake and time to receipt of meningococcal vaccines in newly diagnosed asplenia patients
Autor:
Eleena Koep, Matthew N. O'Brien, Sanya Pasricha, David T. Liss, Andrew J. M. Cooper, Manisha Cherupally, Amisha Wallia, Cassandra Aikman, Emily D. Parker, Ronald T. Ackermann
Publikováno v:
Diabetes. 69
Objective: This study used real-world data to describe treatment patterns in second-line antidiabetic medication (ADM) regimen (Sulfonylureas, DPP-4 inhibitors, GLP-1 RAs, SGLT2 inhibitors, or TZDs) over a fixed 12 month follow-up period. Methods: Me